AnaMar Medical
Lund, Sweden· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
AnaMar Medical is a clinical-stage biotechnology company based in Lund, Sweden, focused on developing novel treatments for fibrotic diseases. The company's lead candidate, AM1476, is a first-in-class, orally bioavailable, and peripherally-acting 5-HT2B receptor antagonist designed to prevent, heal, and slow organ scarring. AnaMar is targeting systemic sclerosis as its initial orphan indication, with a unique dual-action potential to treat both skin and lung manifestations.
Small Molecules